Search research articles
Contact Us
Filters
Showing results (151-160 of 218) with videos related to
Page
of 22
Sort By:
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
EZH2-driven immune evasion defines high-risk pediatric AML with t(16;21) FUS::ERG gene fusion
Nathaniel J Buteyn, Connor G Burke, Vincent J Sartori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2021
Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia
Quy Le, Sommer Castro, Thao Tang, et al.
Blood Advances
|
October 20, 2020
Morphologic remission status is limited compared to ΔN flow cytometry: a Children's Oncology Group AAML0531 report
Lisa Eidenschink Brodersen, Robert B Gerbing, M Laura Pardo, et al.
Pediatric Blood & Cancer
|
October 1, 2021
Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group
Caitlin W Elgarten, Andrew C Wood, Yimei Li, et al.
Blood Advances
|
January 31, 2024
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia
Katherine Tarlock, Robert B Gerbing, Rhonda E Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio <i>FLT3</i>/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031
Jessica A Pollard, Todd A Alonzo, Robert Gerbing, et al.
Leukemia
|
February 15, 2019
Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia
Nicole A McNeer, John Philip, Heather Geiger, et al.
Blood Advances
|
April 7, 2026
DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid Leukemia
Lonneke Verboon, Sonali P Barwe, Meredith Tavenner, et al.
Cell Genomics
|
December 3, 2025
Analysis of error profiles of indels and structural variants in deep-sequencing data
Ying Shao, Quang Tran, Yuan Feng, et al.
Biopreservation and Biobanking
|
November 28, 2017
Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report
Era L Pogosova-Agadjanyan, Anna Moseley, Megan Othus, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 218) with videos related to
Sort By:
Page
of 22
Biorxiv : the Preprint Server for Biology
|
May 27, 2024
EZH2-driven immune evasion defines high-risk pediatric AML with t(16;21) FUS::ERG gene fusion
Nathaniel J Buteyn, Connor G Burke, Vincent J Sartori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2021
Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia
Quy Le, Sommer Castro, Thao Tang, et al.
Blood Advances
|
October 20, 2020
Morphologic remission status is limited compared to ΔN flow cytometry: a Children's Oncology Group AAML0531 report
Lisa Eidenschink Brodersen, Robert B Gerbing, M Laura Pardo, et al.
Pediatric Blood & Cancer
|
October 1, 2021
Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group
Caitlin W Elgarten, Andrew C Wood, Yimei Li, et al.
Blood Advances
|
January 31, 2024
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia
Katherine Tarlock, Robert B Gerbing, Rhonda E Ries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio <i>FLT3</i>/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031
Jessica A Pollard, Todd A Alonzo, Robert Gerbing, et al.
Leukemia
|
February 15, 2019
Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia
Nicole A McNeer, John Philip, Heather Geiger, et al.
Blood Advances
|
April 7, 2026
DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid Leukemia
Lonneke Verboon, Sonali P Barwe, Meredith Tavenner, et al.
Cell Genomics
|
December 3, 2025
Analysis of error profiles of indels and structural variants in deep-sequencing data
Ying Shao, Quang Tran, Yuan Feng, et al.
Biopreservation and Biobanking
|
November 28, 2017
Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report
Era L Pogosova-Agadjanyan, Anna Moseley, Megan Othus, et al.
Page
of 22